Research ArticleCancer

An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors

See allHide authors and affiliations

Science Translational Medicine  04 Oct 2017:
Vol. 9, Issue 410, eaal4291
DOI: 10.1126/scitranslmed.aal4291

Article Information

vol. 9 no. 410

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication November 26, 2016
  • Resubmitted May 26, 2017
  • Accepted for publication August 23, 2017
  • .

Author Information

  1. Takahiro Ishiguro1,
  2. Yuji Sano2,
  3. Shun-ichiro Komatsu3,
  4. Mika Kamata-Sakurai3,
  5. Akihisa Kaneko3,
  6. Yasuko Kinoshita2,
  7. Hirotake Shiraiwa3,
  8. Yumiko Azuma2,
  9. Toshiaki Tsunenari2,
  10. Yoko Kayukawa2,
  11. Yukiko Sonobe2,
  12. Natsuki Ono3,
  13. Kiyoaki Sakata2,
  14. Toshihiko Fujii2,
  15. Yoko Miyazaki2,
  16. Mizuho Noguchi2,
  17. Mika Endo2,
  18. Asako Harada3,
  19. Werner Frings3,
  20. Etsuko Fujii2,
  21. Eitaro Nanba3,
  22. Atsushi Narita3,
  23. Akihisa Sakamoto3,
  24. Tetsuya Wakabayashi3,
  25. Hiroko Konishi3,
  26. Hiroaki Segawa3,
  27. Tomoyuki Igawa3,
  28. Takashi Tsushima2,
  29. Hironori Mutoh2,
  30. Yukari Nishito2,
  31. Mina Takahashi2,
  32. Lorraine Stewart4,
  33. Ehab ElGabry4,
  34. Yoshiki Kawabe2,3,
  35. Masaki Ishigai3,
  36. Shuichi Chiba3,
  37. Masahiro Aoki2,
  38. Kunihiro Hattori2 and
  39. Junichi Nezu5,*
  1. 1Translational Clinical Research Division, Chugai Pharmaceutical Co., Ltd., 1-1 Nihonbashi-Muromachi 2-Chome Chuo-ku, Tokyo 103-8324, Japan.
  2. 2Research Division, Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan.
  3. 3Research Division, Chugai Pharmaceutical Co., Ltd., 1-135 Komakado, Gotemba, Shizuoka 412-8513, Japan.
  4. 4Companion Diagnostics Pharma Services, Ventana Medical Systems Inc., 1910 E Innovation Parkway, Tucson, AZ 85755, USA.
  5. 5Chugai Pharmabody Research Pte. Ltd., 3 Biopolis Drive, Synapse 138623, Singapore.
  1. *Corresponding author. Email: nezujyn{at}chugai-pharm.co.jp

Altmetric

Article usage

Article usage: October 2017 to August 2021

AbstractFullPdf
Oct 201788416151403
Nov 20171095137324
Dec 201766877189
Jan 201868387160
Feb 201844485156
Mar 201843961123
Apr 201842865113
May 201841861105
Jun 20184066578
Jul 20183827282
Aug 201821510882
Sep 20181788591
Oct 201839433313
Nov 20180518230
Dec 20180466181
Jan 20194462159
Feb 201914433216
Mar 201915370284
Apr 201920211243
May 201918155215
Jun 201919164194
Jul 20199218207
Aug 20197166191
Sep 20194188275
Oct 20193203195
Nov 20196154157
Dec 201910158137
Jan 20207215187
Feb 20206166166
Mar 20207194187
Apr 20202188200
May 20201199190
Jun 20202179153
Jul 20206156151
Aug 20203171116
Sep 202014172180
Oct 20204163144
Nov 20206185173
Dec 20208183163
Jan 20215153168
Feb 20214116121
Mar 20212193160
Apr 20214208166
May 20212183179
Jun 20211228191
Jul 20217176167
Aug 2021151

Stay Connected to Science Translational Medicine

Navigate This Article